Sin conexión a internet: se muestra la versión guardada de la página.

ABBOTT LABORATORI…

USUSD
← Al Screener

ABBOTT LABORATORIES (XETRA:ABL) — Biotechnology: Pharmaceutical Preparations. Número de bolsas en las que cotizan las acciones de la empresa: 4. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.

Sobre la Empresa

Sitio Web
abbott.com
Sector
Health Care · Biotechnology: Pharmaceutical Preparations
Sede Central
North Chicago, United States
Consejero Delegado
Robert Ford
Empleados
73 000
Fundada
1888
Cotiza Desde
20.12.2007 (XETRA:ABL)
Acciones en Circulación
1.73 mil M a 2026-06-30
Capital Flotante
1.72 mil M
Capitalización Bursátil
169.83 mil M USD
Insiders
0.49%
Inversores Institucionales
81.79%
Industria (SIC)
Pharmaceutical Preparations
Forma Jurídica
AZUK
ISIN
US0028241000
LEI
HQD377W2YR662HK5JX27
P/E
33.4
Ratio de Reparto
66.7%
FCF
7.38 mil M USD
Pagos / FCF
57%
Deuda
34.0 mil M USD
3.7 a. de FCF
Racha de Dividendos
43 a.
Beneficios, FCF y dividendos pagados — para los 12 meses hasta 31.03.2026 (el último informe de la compañía).
NAV
29.89 USD · P/NAV 3.42
Fecha del Balance31.03.2026
Activos110 mil M USD
− Pasivos57.7 mil M USD
= Patrimonio Total52.7 mil M USD
− Participaciones No Dominantes640 M USD
= NAV (patrimonio de los accionistas de la empresa)52.1 mil M USD
− Fondo de Comercio35.2 mil M USD
− Activos Intangibles17.9 mil M USD
= NAV Tangible−1.04 mil M USD
Acciones1 741 812 429
NAV por Acción29.89 USD
NAV Tangible por Acción−0.59 USD
Precio de la Acción (ABL)88.8600 EUR
P/NAV3.42
Historial del NAV
Fecha del BalanceNAVNAV por Acción
31.03.202652.1 mil M USD29.89 USD
31.12.202552.1 mil M USD30.00 USD
30.09.202551.0 mil M USD29.30 USD
30.06.202550.6 mil M USD29.05 USD
31.03.202548.8 mil M USD28.05 USD
31.12.202447.7 mil M USD27.48 USD
30.09.202439.8 mil M USD22.94 USD
30.06.202439.3 mil M USD22.60 USD
Descripción

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

anuncio

Bolsas y Tickers

BolsaTickerMonedaPrecioTipo
US USA StocksABT principalUSD104.68 +1.66%acciones ordinarias
LSE London Stock Exchange0Q15 IOBUSD103.27 +4.07%acciones ordinarias
MX Mexican Stock ExchangeABT secundariaMXN1 890 +5.88%acciones ordinarias
XETRA XetraABL secundariaEUR88.86 +2.21%acciones ordinarias

Precio en 3 Meses

día alcista día bajista fecha ex-dividendo fecha de pagoPasa el cursor / toca un día — precios de apertura, cierre, máximo y mínimo

Dividendos

Por año, XETRA:ABL: 1.6798 EUR (3 pagos)

ABBOTT LABORATORIES (ABL) paga dividendos trimestralmente. Por año (12 meses hasta e incluyendo el último pago anunciado): 1.6798 EUR por acción (pagos: 3). Eso representa aproximadamente el 1.89% del precio actual de la acción. Según el historial de pagos, se espera la próxima fecha ex-dividendo alrededor de 13.01.2027. Historial de dividendos ininterrumpido: 43 años.

Fecha ExPagoImporte%TipoTicker
2026-07-15—0.5599 EUR0.7/2.8 %trimestralXETRA:ABL
2026-04-15—0.5599 EUR0.6/2.5 %trimestralXETRA:ABL
2026-01-15—0.5599 EUR0.5/2.0 %trimestralXETRA:ABL
2025-10-15—0.5244 EUR0.5/1.8 %trimestralXETRA:ABL
2025-07-15—0.5244 EUR0.5/1.8 %trimestralXETRA:ABL
2025-04-15—0.5244 EUR0.5/1.8 %trimestralXETRA:ABL
2025-01-15—0.5244 EUR0.5/1.8 %trimestralXETRA:ABL
2024-10-15—0.4888 EUR0.5/1.8 %trimestralXETRA:ABL
2024-07-15—0.4888 EUR0.5/2.0 %trimestralXETRA:ABL
2024-04-12—0.4888 EUR0.5/1.8 %trimestralXETRA:ABL
2024-01-11—0.4888 EUR0.5/1.8 %trimestralXETRA:ABL
2023-10-12—0.4533 EUR0.5/2.0 %trimestralXETRA:ABL
2023-07-13—0.4533 EUR0.5/1.8 %trimestralXETRA:ABL
2023-04-13—0.4533 EUR0.5/1.9 %trimestralXETRA:ABL
2023-01-12—0.4533 EUR0.4/1.6 %trimestralXETRA:ABL
2022-10-13—0.4177 EUR0.4/1.6 %trimestralXETRA:ABL
2022-07-14—0.4177 EUR0.4/1.2 %trimestralXETRA:ABL
2022-04-13—0.4177 EUR0.4/0.8 %trimestralXETRA:ABL
2022-01-13—0.4177 EUR0.4/0.4 %trimestralXETRA:ABL

Noticias de Esta Semana

Comunicados de prensa desde la página web para inversores de la empresa, actualizados diariamente. Los enlaces conducen a la página web de la empresa. Los titulares están en el idioma original, como en la página web de la empresa.

Principales Accionistas

TitularParticipaciónAccionesFecha del Informe
BlackRock8.82%152.56 M2026-06-30
Vanguard Capital Managem…6.57%113.75 M2026-06-30
State Street Corporation4.68%80.93 M2026-06-30
Charles Schwab Investmen…3.45%59.67 M2026-06-30
VANGUARD INDEX FUNDS-Van…3.2%55.3 M2026-06-30
Vanguard Portfolio Manag…2.83%49.02 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.61%45.14 M2026-06-30
Geode Capital Management…2.27%39.22 M2026-06-30
Capital Research Global…2.13%36.91 M2026-06-30
Capital International In…2%34.65 M2026-06-30
SCHWAB STRATEGIC TRUST-S…1.9%32.82 M2026-05-31
Morgan Stanley1.54%26.61 M2026-06-30
NORGES BANK1.35%23.35 M2026-06-30
iShares Trust-iShares Co…1.34%23.2 M2026-08-31
Fidelity Concord Street…1.3%22.52 M2026-07-31
SPDR S&P 500 ETF TRUST-S…1.23%21.31 M2026-08-31
WASHINGTON MUTUAL INVEST…1.01%17.53 M2026-07-31
VANGUARD INDEX FUNDS-Van…0.96%16.58 M2026-06-30
SELECT SECTOR SPDR TRT-S…0.72%12.52 M2026-08-31
Investment Co of America0.6%10.33 M2026-06-30
STARKS DANIEL J (Directo…≈0.39%6.75 M2026-04-27
FORD ROBERT B. (Chief Ex…≈0.03%522 6642026-08-25
ALLEN HUBERT L. (Officer…≈0.01%200 2812025-02-25
SALVADORI DANIEL GESUA S…≈0.01%146 3772026-03-02
CONROY KEVIN T (Director…≈0.01%133 7372026-04-24
MORELAND MARY K (Officer…≈0.01%116 1362026-03-02
EARNHARDT LISA D (Office…≈0.01%98 9842026-02-24
SCOGGINS CHRISTOPHER J (…≈0%82 1232026-02-24
WAINER ANDREA F (Officer…≈0%74 3812025-03-03
The Vanguard Group———
BOUDREAU PHILIP P (Chief…——2026-04-23